Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin

BACKGROUND: Continuous infusion of doxorubicin or dexrazoxane pre-treatment prior to bolus doxorubicin are proven strategies to protect against doxorubicin-induced cardiotoxicity. Recently, global longitudinal peak systolic strain (GLS) measured with speckle tracking echocardiography (STE) and high-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiooncology
Autors principals: Li, Jieli, Chang, Hui-Ming, Banchs, Jose, Araujo, Dejka M., Hassan, Saamir A., Wagar, Elizabeth A., Yeh, Edward T. H., Meng, Qing H.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048030/
https://ncbi.nlm.nih.gov/pubmed/32154027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-019-0056-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars